- Home
- XNCR vs ACHC Comparison
XNCR vs ACHC Comparison
Compare XNCR & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | ACHC |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 1.1B |
| IPO Year | 2013 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XNCR | ACHC |
|---|---|---|
| Price | $13.52 | $22.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $22.78 | $19.71 |
| AVG Volume (30 Days) | 429.4K | ★ 3.8M |
| Earning Date | 05-22-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.36 | ★ 1258.33 |
| EPS | N/A | ★ 0.82 |
| Revenue | $125,576,000.00 | ★ $3,153,963,000.00 |
| Revenue This Year | $18.68 | $4.87 |
| Revenue Next Year | N/A | $5.50 |
| P/E Ratio | ★ N/A | $25.41 |
| Revenue Growth | ★ 13.65 | 7.69 |
| 52 Week Low | $6.92 | $11.43 |
| 52 Week High | $18.69 | $33.58 |
Technical Indicators
Market Signals| Indicator | XNCR | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 83.10 |
| Support Level | $12.57 | $20.88 |
| Resistance Level | $15.59 | $25.11 |
| Average True Range (ATR) | 0.83 | 1.00 |
| MACD | 0.24 | 0.68 |
| Stochastic Oscillator | 70.96 | 97.57 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.